vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and NewGenIvf Group Ltd (NIVF). Click either name above to swap in a different company.
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
NewGenIvf Group Ltd is a specialized assisted reproductive technology (ART) service provider. It offers a full range of fertility solutions including in vitro fertilization, preimplantation genetic testing and fertility preservation, primarily serving clients across Greater China and Southeast Asia, including both local and cross-border patients seeking reproductive care.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $7.9M | — |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $749.4K | — | ||
| Q2 25 | $355.8K | — | ||
| Q1 25 | $282.9K | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $655.8K | — | ||
| Q1 24 | $556.2K | — |
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
| Q4 25 | -50.6% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 18.8% | — | ||
| Q1 25 | 13.3% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 17.2% | — | ||
| Q2 24 | 17.3% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | -48.7% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | -23.2% | — | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 8.2% | — | ||
| Q1 24 | 7.1% | — |
| Q4 25 | $-0.46 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $-0.23 | — | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $0.07 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
